The pharmaceutical industry has evolved to be an integration innovator, embracing external discovery while jealously protecting the core business. But this type of open innovation is subject to operator bias and is driven by common industry needs and the blockbuster business model. Join us for our IM Channel One Ask the Expert Q&A on October 1st to learn how open innovation can bring unprecedented access to adjacent industries where unobvious technologies can have a major impact on pharmaceutical innovation.
Image Courtesy of renjith krishnan / FreeDigitalPhotos.net
To read the full, original article click on this link: Live Web Event: Is the Pharmaceutical Innovation Model Broken? And can Open Innovation Mend it? | Innovation Management
